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Depression and anxiety are common mental disorders which cause high disease burden. 
They also are considered risk factors for cardiovascular disease (CVD). CVD carries a high 
disease burden too, due to loss of quality of life and reduction of life expectancy. The 
existing evidence of the interconnectivity of mental and vascular health makes them even 
more interesting and important subjects of study. For many individuals the first warning 
of CVD is a major event, such as a heart attack, stroke, or cardiac death. At the same 
time, it is known that changes in arterial structure and function can be measured already 
on an early, subclinical level. Various markers of (subclinical) CVD can be distinguished, 
based on e.g. the vascular bed concerned (central or more peripheral) and the underlying 
pathophysiological process. As to the latter, athero- and arteriosclerosis are two separate 
but often overlapping conditions that affect medium and large arteries. Atherosclerosis or 
narrowing of the arteries is the process by which fatty substances, calcium particles and 
waste products build up along the (damaged) linings of arterial walls. As a consequence, 
increasingly less blood – and therefore less nutrition and oxygen – is able to reach the bodily 
organs and tissue. Arteriosclerosis or arterial stiffening refers to the progressive loss of 
elasticity of the arterial wall, due to which the risk of endothelial damage increases and the 
heart is hindered to supply sufficient blood flow. Both atherosclerosis and arteriosclerosis 
have been shown to predict cardiovascular events.
 Previous studies regarding depression or anxiety and subclinical cardiovascular 
disease have yielded inconsistent results. A lot of studies were also based on small 
samples and therefore could not adequately adjust for potential confounders, nor study 
the influence of specific psychiatric characteristics. Besides, associations between anxiety 
(disorders) and subclinical cardiovascular disease until now have sparsely been studied. 
Further, as depression and anxiety are often found to be co-morbid, it would be important 
to study the association of depression an anxiety with subclinical cardiovascular disease in 
concert.
 The aim of this thesis is to contribute to knowledge on the association between 
depression, anxiety and subclinical CVD. The primary research question is: Are depressive 
or anxiety disorders, or specific psychiatric characteristics, associated with increased 
atherosclerosis or arterial stiffness? Additionally, it is investigated whether psychological 
distress is associated with atherosclerosis; whether lifestyle or hypothalamic-pituitary-
adrenal axis reactivity may play a role in potential associations between mental and 
vascular health; and whether depressive or anxiety disorders are associated with (clinical) 
CVD.
 
Current depression and/or anxiety disorder and peripheral arterial disease
In Chapter 2 we compared the presence of peripheral atherosclerosis between people 
with or without depressive or anxiety disorders. We used data from 2717 participants of 
the baseline measurement of the Netherlands Study of Depression and Anxiety (NESDA). 
Participants for the current study were aged 18 through 65 years and had no history of 
CVD. Peripheral atherosclerosis was measured using the ankle-brachial index. This index is 
based on the systolic blood pressure measured in the ankle and the arm. When the ankle 
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pressure is lower than that of the arm (ankle-brachial index ≤ 0.9), this is evidence for 
decreased blood flow in the legs due to atherosclerosis. 1619 participants had a depressive 
and/or anxiety disorder in the year prior to the measurement (current), and 496 participants 
had been depressed or anxious ever before (remitted). We additionally had a group of 602 
healthy controls, without a history of depressive or anxiety disorders. 
 As compared with healthy controls, participants with a current depression or anxiety 
disorder almost 3-times more often had peripheral atherosclerosis. Within this group with 
current psychopathology, the severity and duration of depressive or anxiety symptoms 
was not of influence, nor was the use of antidepressant medication. No increased risk was 
found for those with remitted diagnoses of depression or anxiety disorders. This might 
be explained by the retrospectively obtained diagnoses (which are less reliable). Another 
possibility is that the group with psychopathology also includes the more chronically 
depressed or anxious subjects. Our observations suggest that both depression and anxiety 
disorders are associated with increased risk of atherosclerosis.
Late-onset depression and thickness of the carotid arterial wall
In Chapter 3 we investigated whether the arterial wall of people with a depression or 
anxiety disorder was more increased than that of healthy controls. Thickened layers in 
the arterial wall, e.g. damaged endothelium where cholesterol, platelets and calcium can 
start to build up, can cause narrowing or other trouble after part of the ‘plaque’ gets loose 
and ends up travelling in the blood stream. The carotid arteries were visualized using 
ultrasonography in 649 participants of the NESDA 2-year assessment. The thickness of the 
carotid arterial wall (i.e. intima-media thickness) was calculated and the presence of local 
protrusive areas (plaques) was registered. 
 In general, no difference was found between the 470 participants with a current or 
remitted depression or anxiety disorders and 179 controls with respect to arterial wall 
thickness. In the group with psychopathology, increased severity or duration of symptoms 
was not associated with carotid atherosclerosis either. However, among those who ever 
had a depressive disorder, the age of the first depression onset did matter. The later the age 
of first depression onset, the likelier the probability one showed an increased intima-media 
thickness and plaque presence. Because atherosclerosis is a process taking decennia, these 
findings better suit the hypothesis that (subclinical) CVD can cause depression than vice 
versa. Based on existing knowledge, we think this might be caused by plaques in particular 
brain areas that are responsible for emotion regulation. Our results thus suggest that poor 
vascular health might contribute to someone’s vulnerability to develop a depression. 
Current depression and/or anxiety disorder and arterial stiffness
In Chapter 4 we investigated whether depression or anxiety disorders, or specific psychiatric 
characteristics, were associated with arterial stiffness. Arterial stiffness increases the risk 
of endothelial damage and causes the heart to work harder. Local elasticity of the carotid 
arteries (distensibility-coefficient) was measured using ultrasonography; aortic stiffness 
(central augmentation index) was estimated based on radial artery waveforms recorded 
with an applanation tonometer and a transfer function. The analyses were based on 618 
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participants of the NESDA 2-year assessment, with 29% having a current (last month) 
diagnosis of depressive or anxiety disorder, 44% having remitted depression or anxiety 
and 27% without a diagnosis of depressive / anxiety disorder ever (controls). 
 In general, participants with a current depression or anxiety disorder showed an 
increased augmentation index as compared with controls. People who had suffered from 
a depressed or anxious episode in the past but were currently recovered, did not differ 
from controls with respect to central arterial stiffness. It therefore can be suggested that 
arterial stiffening might be a state effect, which returns to normal when depressed or 
anxious episodes fade away. We further observed that subjects who were longer or more 
severely exposed to anxiety or depressive symptoms showed increased stiffness, fitting 
into a dose-response relationship. Regarding carotid distensibility coefficient, no significant 
differences were found between depressive/anxious subjects and healthy controls. This 
could be due to heterogeneity in aging of different arterial regions (the aorta might be 
more prone to vascular stiffening than peripheral arteries).
Anxiety sensitivity, carotid atherosclerosis and arterial stiffness
Chapter 5 describes a study on whether cognitive vulnerability (‘sensitivity’) to depression 
or anxiety is associated with subclinical CVD. Depressive and anxiety disorders often 
co-occur and partially include the same symptoms. Since previous studies investigating 
cardiovascular risk mostly have focused on either depression or anxiety disorders, 
it is not clear yet what exactly drives CVD risk in depressed or anxious subjects. We 
therefore investigated associations with subclinical CVD at the level of trait-like, cognitive 
vulnerability to depression or anxiety, using data from 635 participants of the NESDA 
2-year assessment. Depression sensitivity measures the extent to which dysfunctional 
cognitions (e.g. hopelessness, aggression, rumination) are triggered during normal mood, 
that is cognitive reactivity to sadness. Anxiety sensitivity assesses the degree to which 
one is concerned about possible negative consequences of bodily, cognitive or publicly 
observable sensations (e.g. increased heart rate, concentration problems, blushing). 
Carotid bifurcation intima-media thickness, presence of carotid plaques and central 
augmentation index were taken to be indicators of subclinical CVD.
 Apart from a tendency of higher aggression reactivity to be associated with carotid 
plaque, no significant associations were found for any of the depression sensitivity 
measures. However, subjects scoring higher on anxiety sensitivity both had a higher 
likelihood of plaque presence and showed increased arterial stiffness. These findings 
suggest that cognitive vulnerability to anxiety, rather than depression sensitivity, is 
associated with indicators of increased cardiovascular risk. The current study further 
stresses the importance of including anxiety disorders among the potential CVD risk 
factors.
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Psychological distress and coronary calcification
In Chapter 6 we studied psychological distress (current or long-term) in association with 
subclinical coronary artery calcification. Additionally, we investigated whether someones 
hormonal reactivity to stress could play a role in this association. We analysed data from 
the Heart Scan Study (London, Great Brittan), which is based on the Whitehall II cohort. 527 
healthy men and women (aged 53-76) without a history of CVD or depression came for an 
extra laboratory visit. A heart scan was made in order to measure coronary calcification and 
salivary cortisol was measured before and after stress-tasks. Participants also completed 
a questionnaire (Mental Health Index; MHI-5) about how they had felt (nervous, down 
in dumps, calm, happy, low) over the past month. Long-term distress was based on the 
averaged scores of six assessments over the 15 preceding years. 
 The more chronic psychological distress people had, the higher was their likelihood 
of having severe coronary calcification. No significant associations were found between 
current distress and calcification. Psychological distress in general was not associated with 
increased cortisol stress-responses. However, people who both reported chronic distress 
ánd showed increased hormonal stress responses had the highest risk of severe coronary 
calcification; these ‘hypercortisolemically distressed’ were 8-times more likely of having 
sever calcification as compared with people who for a long time had been ‘happy in one’s 
skin’ and didn’t show a large cortisol peak following stress tasks. Long-term psychological 
distress was not associated with mild/moderate coronary calcification. This could imply 
that exposure to psychological distress speeds up the progression of atherosclerosis, 
rather than brings about its initial development. 
Current anxiety disorders (and depression) and cardiovascular disease
In Chapter 7, data from the NESDA baseline assessment were analyzed in order to 
investigate whether CVD was more often found in people with a depression and/or anxiety 
disorder as compared with controls. Besides, we studies specific psychiatric characteristics 
in association with CVD. The presence of CVD was based on self-report and medication 
use and subsequently categorized as stroke and coronary heart disease (angina pectoris, 
myocardial infarction, coronary angioplasty and coronary artery bypass grafting). 
Participants were 2315 subjects with a depression or anxiety disorder in the year prior to 
assessment (current) or earlier in life (remitted) and 492 healthy controls. Several clinical 
characteristics were measured, such as comorbidity, severity and duration of symptoms, 
and use of psychotropic medication. 
 People with a current anxiety disorder about 3-times more often had coronary heart 
disease. The odds were 2.7 for subjects who only had a diagnosis of anxiety disorder, and 
3.5 for those who also had a comorbid depressive disorder. No significant association was 
found between depression or anxiety and stroke. Likewise, no associations with CVD were 
found for people with a current depression only, or with remitted depression or anxiety. 
Severity of depressive or anxiety symptoms was associated with coronary heart disease in 
a dose-response manner. This study among people with depression and/or anxiety shows 
that those with anxiety disorders carry increased risk of coronary heart disease. 
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General discussion
Briefly, the results presented in this thesis show that both depressive and anxiety disorders 
are correlates of subclinical CVD. More specifically, peripheral atherosclerosis and increased 
central arterial stiffness are more often found in people with current depression or anxiety 
as compared with controls. Clinical CVD is more often found in subjects with a current 
anxiety disorder, but comorbid depression increases the odds even further. Besides, some 
evidence was found in favor of a dose-response relationship between depression, anxiety 
and CVD risk: the more depression/anxiety symptoms or long-term psychological distress 
reported, the more increased the central arterial stiffness, the likelihood of subclinical 
coronary calcification or clinical coronary heart disease. The associations between 
mental and vascular health were not exactly the same along the arterial tree, since no 
significant associations were found between depression, anxiety and (sub-/)clinical 
CVD in the cerebrovascular bed (i.e. carotid atherosclerosis, carotid stiffness, stroke). 
However, late-onset depression was associated with carotid atherosclerosis. It is not likely 
that an unhealthy lifestyle directly explains the subclinical CVD in depressed or anxious 
participants. Although lifestyle factors separately were associated with CVD outcomes, 
they hardly changed the associations found when included as covariates. 
 Because of the primarily cross-sectional character of the studies described in this 
thesis, no conclusions can be drawn about the causality of the associations between mental 
and vascular health. Despite that, our observations seem to imply that monitoring the 
cardiovascular risk of depressed and anxious patients is no frivolous luxury: they appear 
to be a high-risk population with respect to both increased atherosclerosis and arterial 
stiffness.
